The epidemiology and economics of chronic obstructive pulmonary disease
- PMID: 17878461
- DOI: 10.1513/pats.200701-001FM
The epidemiology and economics of chronic obstructive pulmonary disease
Abstract
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease responsible for a large human and economic burden around the world. Cigarette smoking is the main risk factor for COPD in the developed world, although other important risk factors include occupational exposures, air pollution, airway hyperresponsiveness, asthma, and genetic predisposition. In most of the world, COPD prevalence and mortality continue to rise in response to increases in smoking, particularly by women and adolescents. COPD is also an important cause of disability, and is linked to comorbid diseases, such as depression and cardiovascular disease, which adds to the large economic burden associated with this disorder. Better public health and medical interventions that target both the risk factors for COPD and look toward earlier intervention may decrease the growing public health impact of COPD.
Similar articles
-
Epidemiology and global impact of chronic obstructive pulmonary disease.Semin Respir Crit Care Med. 2005 Apr;26(2):204-10. doi: 10.1055/s-2005-869539. Semin Respir Crit Care Med. 2005. PMID: 16088437 Review.
-
Chronic obstructive pulmonary disease: definition and epidemiology.Respir Care. 2003 Dec;48(12):1185-91; discussion 1191-3. Respir Care. 2003. PMID: 14651759 Review.
-
An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2010 Sep 1;182(5):693-718. doi: 10.1164/rccm.200811-1757ST. Am J Respir Crit Care Med. 2010. PMID: 20802169 Review.
-
Outdoor and indoor air pollution and COPD-related diseases in high- and low-income countries.Int J Tuberc Lung Dis. 2008 Feb;12(2):115-27. Int J Tuberc Lung Dis. 2008. PMID: 18230243 Review.
-
Epidemiology of chronic obstructive pulmonary disease: health effects of air pollution.Respirology. 2006 Sep;11(5):523-32. doi: 10.1111/j.1440-1843.2006.00886.x. Respirology. 2006. PMID: 16916323 Review.
Cited by
-
Resource allocation and the burden of co-morbidities among patients diagnosed with chronic obstructive pulmonary disease: an observational cohort study from Danish general practice.BMC Health Serv Res. 2016 Apr 6;16:121. doi: 10.1186/s12913-016-1371-0. BMC Health Serv Res. 2016. PMID: 27052659 Free PMC article.
-
Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients.AIDS. 2016 Jan 28;30(3):455-63. doi: 10.1097/QAD.0000000000000940. AIDS. 2016. PMID: 26765938 Free PMC article.
-
Auto-antibodies against carbonyl-modified vimentin in COPD: potential role as a biomarker.J Inflamm (Lond). 2025 Feb 12;22(1):7. doi: 10.1186/s12950-025-00434-0. J Inflamm (Lond). 2025. PMID: 39934770 Free PMC article.
-
Inhibition of serine proteases by a new class of cyclosulfamide-based carbamylating agents.Arch Biochem Biophys. 2008 Jul 15;475(2):115-20. doi: 10.1016/j.abb.2008.04.020. Epub 2008 Apr 22. Arch Biochem Biophys. 2008. PMID: 18457652 Free PMC article.
-
Intravenous and intratracheal mesenchymal stromal cell injection in a mouse model of pulmonary emphysema.COPD. 2014 Jun;11(3):310-8. doi: 10.3109/15412555.2013.854322. Epub 2013 Dec 2. COPD. 2014. PMID: 24295402 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical